AstraZeneca, Daiichi Sankyo Win First Tumor-Agnostic HER2 FDA Approval for Enhertu 4/8/2024

FDA Again Rejects Supernus Drug-Device Combo for Parkinson’s Disease 4/8/2024

Opinion: The Next Generation of ADCs Will Improve Cancer Treatment 4/8/2024

Flagship-Backed Prologue Launches with $50M to DELVE into Viral Proteome 5/7/2024

Vertex Touts 13% Revenue Jump, Beats Profit Estimates on Strong Cystic Fibrosis Performance 5/7/2024

AAV Manufacturing Takes Center Stage at ASGCT24 5/7/2024

ADC Therapeutics Posts Early Phase II Lymphoma Data for Zynlonta as Revenue Drops 5.8% 5/7/2024

Preliminary Findings Point to Low Risk of Secondary Cancers from CAR-T Therapies 5/7/2024

FDA Sets Date for Eli Lilly’s Donanemab Adcomm While Pondering Changes to Format 5/7/2024

ASGCT 2024 Comes at Pivotal Time for Gene and Cell Therapy Sector 5/6/2024

Opinion: Can Ketamine Be Safely Used at Home? 5/6/2024

5 DMD Data Readouts to Watch in 2024 5/6/2024

AAVs in Focus at ASGCT: Improved Precision, Targeting Common Diseases 5/6/2024

FDA Greenlights BMS, J&J CAR-T Therapies for Earlier Multiple Myeloma Treatment 4/6/2024

Bayer Cuts 1,500 Jobs and Lowers 2024 Earnings Guidance as Q1 Sales Dip 5/14/2024

Novo Nordisk’s Wegovy Sustains Weight Loss for Four Years in Two Studies 5/14/2024

Cytokinetics’ Phase III Data Sets Up Cardiomyopathy Challenge to BMS 5/14/2024

AbbVie, Gilgamesh Sign Potential $2B Deal to Develop Next-Gen Psychedelics for Psychiatric Disorders 5/14/2024

Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines 5/14/2024

Biopharma Layoff Tracker 2024: Bayer, Ginkgo, Marinus and More Cut Staff 5/14/2024